David N. McMurray,3
Vijay K. Arora,4 and
Suman Laal1,2,5*
Department of Pathology, New York University School of Medicine, New York, New York 10016,1 New York Harbor Health Care System, New York, New York 10010,2 Department of Medical Microbiology and Immunology, Texas A&M University, System Health Science Center, College Station, Texas 77843,3 Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases, New Delhi 110030, India,4 Veterans Affairs Medical Center, New York, New York 100105
Received 18 January 2005/ Returned for modification 16 February 2005/ Accepted 15 March 2005
Clinical tuberculosis (TB), whether noncavitary or cavitary, is the late stage of a chronic disease process, since Mycobacterium tuberculosis is a slowly growing organism. Our studies have shown that the profiles of antigenic proteins expressed by the in vivo bacteria that elicit antibodies differ in cavitary and noncavitary TB (K. Samanich, J. T. Belisle, and S. Laal, Infect. Immun. 69:4600-4609, 2001). To gain insight into antigenic proteins expressed during incipient, subclinical TB, an expression library of M. tuberculosis genomic DNA was screened with sera obtained during subclinical TB from guinea pigs infected with aerosols of M. tuberculosis H37Rv. One of the proteins recognized by antibodies elicited during subclinical TB infection of guinea pigs is the 309-kDa PPE55 (Rv3347c) protein. Genomic hybridization studies suggest that the PPE55 gene is specific to the M. tuberculosis complex and is present in a majority of clinical isolates tested. Antibodies to the C-terminal,
100-kDa fragment of PPE55 (PPE-C) were detectable in sera from 29/30 (97%) human immunodeficiency virus-negative/TB-positive (HIV TB+) patients and 17/24 (71%) HIV+ TB+ patients tested but not in sera from purified-protein derivative-positive healthy controls, suggesting that the in vivo expression of PPE55 protein correlates with active M. tuberculosis infection. Anti-PPE-C antibodies were also detected in retrospective sera obtained months prior to manifestation of clinical TB from 17/21 (81%) HIV+ TB+ individuals tested, providing evidence that the protein is expressed during incipient, subclinical TB in HIV-infected humans. Thus, PPE55 is a highly immunogenic protein that may be useful for differentiating between latent TB and incipient, subclinical TB.
Present address: Bayer Diagnostics, Tarrytown, NY 10591.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|